Pharmaceuticals & Biotechnology · disclosure as of 2026-09-30
Abbott India Ltd.
Held by 193 funds in our universe · avg weight 0.95% · range 0.00% to 5.94%
Fundamentals
P/E history band: 43-49 · currently cheap vs own history
Technicals · split/bonus-adjusted
Price as of 2026-10-21
Funds by category
Showing only Hybrid – Dynamic Asset Allocation or Balanced Advantage funds. clear filter
6 Hybrid – Dynamic Asset Allocation or Balanced Advantage funds holding this stock , sorted by the stock's weight in each fund
| Fund | Category | % of fund in this stock | As of |
|---|---|---|---|
|
PGIM India Balanced Advantage Fund - Direct Plan - Direct Growth
PGIM India Mutual Fund |
Hybrid · Dynamic Asset Allocation or Balanced Advantage | 0.90% | 2026-09-30 |
|
HSBC Balanced Advantage Fund - Direct Plan - Growth
HSBC Mutual Fund |
Hybrid · Dynamic Asset Allocation or Balanced Advantage | 0.85% | 2026-08-31 |
|
Aditya Birla Sun Life Balanced Advantage Fund - Direct Plan - GROWTH
Aditya Birla Sun Life Mutual Fund |
Hybrid · Dynamic Asset Allocation or Balanced Advantage | 0.74% | 2026-09-30 |
|
Canara Robeco Balanced Advantage Fund - Direct Plan - Growth Option
Canara Robeco Mutual Fund |
Hybrid · Dynamic Asset Allocation or Balanced Advantage | 0.67% | 2026-09-30 |
|
Edelweiss Balanced Advantage Fund - Direct Plan - Growth
Edelweiss Mutual Fund |
Hybrid · Dynamic Asset Allocation or Balanced Advantage | 0.38% | 2026-09-30 |
|
NJ Balanced Advantage Fund - Direct Plan - Growth Option
NJ Mutual Fund |
Hybrid · Dynamic Asset Allocation or Balanced Advantage | 0.25% | 2026-09-30 |
Holdings sourced from scheme portfolios as published by their AMCs each month under SEBI rules. "% of fund in this stock" is the position weight inside each fund, NOT the rupee value of any individual investor's exposure.